The notion of using ketamine as an anti-depressant is gathering steam on the back of enlightening research that has shown us how it can suppress the brain’s “anti-reward” center, mend broken neural circuits and interact with serotonin receptors to boost the release of dopamine. A new study has shown how this might work in practice, with chronic suicidality sufferers offered rapid relief through regular oral administration of the drug in clinical settings.